This inventor holds 1 USPTO granted patent. Top assignee: Scripps Research Institute. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Innovations of Anders M Eliasen in Antiviral Research
Introduction
Anders M Eliasen is a notable inventor based in Los Angeles, CA. He has made significant contributions to the field of antiviral research, particularly in the development of pharmaceutical compositions aimed at combating human immunodeficiency virus (HIV). His work is characterized by a commitment to advancing medical science and improving patient outcomes.
Latest Patents
Eliasen holds a patent for "Antiviral prodrugs and pharmaceutical compositions thereof - Diesters of 4'-ethynyl-2-fluoro-2′-deoxyadenosine and aqueous parenteral suspensions thereof." This innovative patent provides extended in vivo viral suppression of HIV, showcasing his dedication to addressing critical health challenges.
Career Highlights
Anders M Eliasen is affiliated with the Scripps Research Institute, where he continues to engage in groundbreaking research. His work at this prestigious institution has allowed him to collaborate with leading scientists and contribute to significant advancements in antiviral therapies.
Conclusion
Anders M Eliasen's contributions to antiviral research and his innovative patent demonstrate his vital role in the fight against HIV. His work not only reflects his expertise but also his commitment to improving public health through scientific innovation.